{
  "pmcid": "3890166",
  "sha256": "9b15298306957971b9c973aa7edc8c25562bf8e5e890c438fdadf0df0451d368",
  "timestamp_utc": "2025-11-09T22:40:09.346480+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 11.050124223602484,
    "reading_ease": 35.346159420289865,
    "word_count": 230
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Thoracolumbosacral Orthoses with Abdominal Cutout on Pulmonary Function"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "In this randomised controlled trial, 20 healthy adults were recruited"
      },
      "Participants": {
        "score": 1,
        "evidence": "20 healthy adults were recruited"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomly assigned to wear a custom-molded TLSO with a reattachable abdominal cutout"
      },
      "Objective": {
        "score": 1,
        "evidence": "This study evaluates the effect of an abdominal cutout on pulmonary function in healthy adults."
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "The primary outcome was pulmonary function, measured by forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) at rest and after exercise."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomisation was conducted using a computer-generated sequence, and allocation was concealed."
      },
      "Blinding": {
        "score": 1,
        "evidence": "Blinding was applied to outcome assessors."
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "20 healthy adults were recruited"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "The abdominal cutout (open) increased FVC at rest (95% CI, 3.79–4.76; p = 0.007) and postexercise (95% CI, 3.80–4.73; p = 0.025) compared with the closed TLSO."
      },
      "Harms": {
        "score": 1,
        "evidence": "No adverse events were reported."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 16,
    "max_score": 25
  }
}